Klaus Elenius profile picture
Klaus
Elenius
Professor, Institute of Biomedicine
Director, BioCity Turku
Turku Bioscience Centre
MD, PhD, professor

Contact

+358 29 450 4393
+358 50 514 2307
Tykistökatu 6 A
20520
Turku

Research


ACTIONABLE RECEPTOR TYROSINE KINASE SIGNALING

Our goal is to understand how receptor tyrosine kinases (RTK) regulate the pathogenesis of human diseases, such as cancer. This information is needed for the development of molecularly targeted therapies. To recognize aberrations of RTK signaling in diseased tissue our laboratory also works on the molecular mechanism by which RTKs control normal processes, such as embryonic development. The work mainly focuses on the ErbB family of RTKs. Our laboratory has contributed to the field by e.g. by characterizing novel RTK signaling mechanisms, by identifying novel ErbB4 isoforms, and by determining the role of ErbBs and their ligands in angiogenesis.

Current topics

  • Screens for predictive RTK mutations
  • Novel RTK signaling mechanisms
  • Development of preclinical models for development novel RTK inhibitors
  • Sequencing of RTK inhibitor drug administration with cytotoxic agents
  • In vitro “basket trials” with ErbB inhibitor drugs
  • RTK signaling in angiogenesis and cardiovascular diseases
  • RTKs in pediatric malignancies
  • Biological role of novel ErbB4 isoforms in diseases and development

Elenius Lab members

  • Anne Jokilammi, PhD
  • Elli Narvi, PhD
  • Deepankar Chakroborty, MSc
  • Juho Heliste, MD
  • Marika Koivu, MSc 
  • Johannes Merilahti, MSc
  • Veera Ojala, MSc
  • Janne Nordberg, MD
  • Fred Saarinen, MSc
  • Katri Vaparanta, MSc
  • Kaisa Aalto, BM
  • Maria Helkkula, BM
  • Matias Mäenpää, BM
  • Peppi Kirjalainen, BM
  • Jori Torkkila, BM

Publications

Sort by:

Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth in vivo (2024)

ChemBioChem
Honkanen, Meija; Narvi, Elli; Ojala, Veera; Jokilammi, Anne; Rantakari, Pia; Kronqvist, Pauliina; Kähäri, Veli-Matti; Veräjänkorva, Esko; Kurppa, Kari J; Rahkila, Jani; Ekambaram, Ramesh; Savolainen, Johannes; Leino, Reko; Elenius, Klaus
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

STAT5b is a key effector of NRG-1/ERBB4-mediated myocardial growth (2023)

EMBO Reports
Vaparanta Katri, Jokilammi Anne, Paatero Ilkka, Merilahti Johannes A, Heliste Juho, Hemanthakumar Karthik Amudhala, Kivelä Riikka, Alitalo Kari, Taimen Pekka, Elenius Klaus
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations (2022)

Cancer Research Communications
Chakroborty Deepankar, Ojala Veera K., Knittle Anna M., Drexler Jasmin, Tamirat Mahlet, Ruzicka Regina, Bosch Karin, Woertl Johanna, Schmittner Susanne, Elo Laura L., Johnson Mark S., Kurppa Kari J., Solca Flavio, Elenius Klaus
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries (2021)

Nature Communications
Gharahkhani Puya, Jorgenson Eric, Hysi Pirro, Khawaja Anthony P., Pendergrass Sarah, Han Xikun, Ong Jue Sheng, Hewitt Alex W., Segrè Ayellet V., Rouhana John M., Hamel Andrew R., Igo Jr Robert P., Choquet Helene, Qassim Ayub, Josyula Navya S., Bailey Jessica N. Cooke, Bonnemaijer Pieter W. M., Iglesias Adriana, Siggs Owen M., Young Terri L., Vitart Veronique, Thiadens Alberta A. H. J., Karjalainen Juha, Uebe Steffen, Melles Ronald B., Nair K. Saidas, Luben Robert, Simcoe Mark, Amersinghe Nishani, Cree Angela J., Hohn Rene, Poplawski Alicia, Chen Li Jia, Rong Shi-Song, Aung Tin, Eranga Nishanthie Vithana, NEIGHBORHOOD consortium, ANZRAG consortium, Biobank Japan project, UK Biobank Eye and Vision Consortium, GIGA study group, 23 and Me Research Team, Tamiya Gen, Shiga Yukihiro, Yamamoto Masayuki, Nakazawa Toru, Currant Hannah, Birney Ewan, Wang Xin, Auton Adam, Lupton Michelle K., Martin Nicholas G., Ashaye Adeyinka, Olawoye Olusola, Williams Susan E., Akafo Stephen, Ramsay Michele, Hashimoto Kazuki, Kamatani Yoichiro, Akiyama Masato, Momozawa Yukihide, Foster Paul J., Khaw Peng T., Morgan James E., Strouthidis Nicholas G., Kraft Peter, Kang Jae H., Pang Chi Pui, Pasutto Francesca, Mitchell Paul, Lotery Andrew J., Palotie Aarno, van Duijn Cornelia, Haines Jonathan L., Hammond Chris, Pasquale Louis R., Klaver Caroline C. W., Hauser Michael, Khor Chiea Chuen, Mackey David A., Kubo Michiaki, Cheng Ching-Yu, Craig Jamie E., MacGregor Stuart, Wiggs Janey L.; FinnGen Study
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection (2021)

Nature Medicine
Zekavat Seyedeh M., Lin Shu-Hong, Bick Alexander G., Liu Aoxing, Paruchuri Kaavya, Wang Chen, Uddin Md Mesbah, Ye Yixuan, Yu Zhaolong, Liu Xiaoxi, Kamatani Yoichiro, Bhattacharya Romit, Pirruccello James P., Pampana Akhil, Loh Po-Ru, Kohli Puja, McCarroll Steven A., Kiryluk Krzysztof, Neale Benjamin, Ionita-Laza Iuliana, Engels Eric A., Brown Derek W., Smoller Jordan W., Green Robert, Karlson Elizabeth W., Lebo Matthew, Ellinor Patrick T., Weiss Scott T., Daly Mark J., The Biobank Japan Project, Terao Chikashi, Zhao Hongyu, Ebert Benjamin L., Reilly Muredach P., Ganna Andrea, Machiela Mitchell J., Genovese Giulio, Natarajan Pradeep; FinnGen Consortium
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))